Evidence map›Paper›PMID 38793571›Full record

ReviewViruses2024

Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.

Juan Luis Chávez-Pacheco, Manuel Castillejos-López, Laura M Hernández-Regino, Liliana Velasco-Hidalgo, Marta Zapata-Tarres, Valeria Correa-Carranza, Guillermo Rosario-Méndez, Rehotbevely Barrientos-Ríos, Arnoldo Aquino-Gálvez, Luz María Torres-Espíndola

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Juan Luis Chávez-PachecoPharmacology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.ORCID 0000-0001-6919-4497
Manuel Castillejos-LópezEpidemiology and Infectology, National Institute of Respiratory Diseases, Mexico City 14080, Mexico.ORCID 0000-0001-8689-9755
Laura M Hernández-ReginoPharmacology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
Liliana Velasco-HidalgoOncology Service, National Institute of Pediatrics, Mexico City 04530, Mexico.
Marta Zapata-TarresHead of Research Coordination at Mexican Social Security Institute Foundation, Mexico City 06600, Mexico.
Valeria Correa-CarranzaPharmacology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
Guillermo Rosario-MéndezPharmacology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
Rehotbevely Barrientos-RíosCytogenetics Laboratory, Department of Human Genetics, National Institute of Pediatrics, Mexico City 04530, Mexico.
Arnoldo Aquino-GálvezMolecular Biology Laboratory, Pulmonary Fibrosis Department, National Institute of Respiratory Diseases, Mexico City 14080, Mexico.ORCID 0000-0002-2869-5516
Luz María Torres-EspíndolaPharmacology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.ORCID 0000-0001-9929-9361

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has resulted in millions of fatalities worldwide. The case of pediatric cancer patients stands out since, despite being considered a population at risk, few studies have been carried out concerning symptom detection or the description of the mechanisms capable of modifying the course of the COVID-19 disease, such as the interaction and response between the virus and the treatment given to cancer patients. By synthesizing existing studies, this paper aims to expose the treatment challenges for pediatric patients with COVID-19 in an oncology context. Additionally, this updated review includes studies that utilized the antiviral agents Remdesivir and Paxlovid

Indexed as

AlanineAntiviral AgentsCOVID-19NeoplasmsSARS-CoV-2Adenosine MonophosphateChildCOVID-19 Drug TreatmentHumansPandemicsAdenosine MonophosphateAlanineAntiviral AgentsremdesivirCOVID-19pediatric cancerSARS-CoV-2treatment

Identifiers

PMID38793571
PMCPMC11125850

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.